| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Bala Mohan | SVP, Chief Development Officer | Sale+OE | 1,884 | $1.90 | $3,579.60 | -3.3% | |
| Oct 3, 2024 | Deschuytner Brian | SVP, COO &CFO | Sale+OE | 13,687 | $1.98 | $27,150.08 | -6.6% | |
| Oct 3, 2024 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 13,687 | $1.98 | $27,150.08 | -9.3% | |
| Oct 3, 2024 | Bala Mohan | SVP, Chief Development Officer | Sale+OE | 13,687 | $1.98 | $27,150.08 | -11.4% | |
| Oct 3, 2024 | Mandelia Ashish | VP, Chief Accounting Officer | Sale+OE | 8,216 | $1.98 | $16,297.56 | -7.7% | |
| Oct 3, 2024 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Sale+OE | 13,687 | $1.98 | $27,150.08 | -2.8% | |
| Sep 12, 2024 | Huber Martin H. Jr. | President, CEO | Sale+OE | 50,423 | $1.76 | $88,744.48 | -30.2% | |
| Jan 16, 2024 | Protopapas Anna | Director | Sale+OE | 29,399 | $2.71 | $79,671.29 | -19.0% | |
| Jan 16, 2024 | Carvajal Alejandra | SVP, Chief Legal Officer | Sale+OE | 4,381 | $2.71 | $11,872.51 | -13.8% | |
| Jan 16, 2024 | Misra Tushar | SVP, Chief Manuf. Officer | Sale+OE | 3,357 | $2.71 | $9,097.47 | -15.7% |